GlassScriptPhysician profile
Aaron Hilton
NPI 1306106794
$1,659.66
in general payments reported to CMS, 2019-2025
14 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.49 · 2020: $32.02 · 2021: $269 · 2022: $321 · 2023: $358 · 2024: $265 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.26 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $860.97 | 2019-2025 | |
| Genzyme Corporation | $233.03 | 2019-2025 | |
| Glaxosmithkline, LLC. | $204.26 | 2023-2025 | Nucala |
| Aerin Medical INC. | $70.02 | 2022-2024 | |
| Inspire Medical Systems, INC. | $51.92 | 2023-2025 | Inspire |
| Kerecis Limited | $48.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Regeneron Healthcare Solutions, INC. | $39.19 | 2021-2025 | Dupixent |
| Alk-Abello, INC | $38.43 | 2019-2021 | |
| Acclarent, INC | $27.25 | 2023 | Acclarent Aera, Trudi Nav Cable |
| Amgen INC. | $21.40 | 2025 | |
| Smith+Nephew, INC. | $17.65 | 2022 | |
| Integra Lifesciences Corporation | $16.97 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Medtronic, INC. | $16.63 | 2024 | Pteye Parathyroid Detection System |
| Intersect Ent, INC. | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Hilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.